ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Hawkins Persists In Attacks On NCI Despite Testimony Refuting Charges

November 13, 1981

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

Olaparib Study Demonstrates No Changes In Overall Survival

March 30, 2012

Elizabeth Miller Will Be Named to Cancer Panel

June 17, 1977